Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FGFRキナーゼ阻害剤及び医薬用途
Document Type and Number:
Japanese Patent JP7226804
Kind Code:
B2
Abstract:
Fibroblast Growth Factor Receptor kinase inhibitors and prodrugs thereof of Formula (I) and their use for the treatment of hyper-proliferative diseases such as retinopathy, psoriasis, rheumatoid arthritis, osteoarthritis, septic arthritis, tumour metastasis, periodontal disease, corral ulceration, proteinuria, coronary thrombosis from atherosclerotic plaque, aneurismal aorta, dystrophobic epidermolysis bullosa, degenerative cartilage loss following traumatic joint injury, osteopenias mediated by MMP activity, tempero mandibular joint disease, and demyelating disease of the nervous system.

Inventors:
Paterson, Adam Vaughn
Smale, Jeffrey Bruce
Ashurzadeh, Amir
Guise, Christopher Paul
Squire, Christopher John
Gameji, Suvarnalata Akratiya
Abbatista, Maria Rosalia
Bull, Matthew Roy
Gray, Angus Cheverton
Li, Shwechian
din, ki
Ren, Xiaomei
Jian, Shuan
Tu, Zhenqiao
Application Number:
JP2019548023A
Publication Date:
February 21, 2023
Filing Date:
March 02, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AUCKLAND UNISERVICES LIMITED
Guanzhou Institute of Biomedicine and Health
International Classes:
C07D487/04; A61K31/4375; A61K31/519; A61K31/5377; A61P35/00; A61P35/02; A61P43/00; C07D471/04
Domestic Patent References:
JP2012520295A
Foreign References:
WO2014182829A1
CN104418860A
WO2016192609A1
Other References:
BUNDGAARD H,NOVEL CHEMICAL APPROACHES IN PRODRUG DESIGN,DRUGS OF THE FUTURE,ES,PROUS SCIENCE,1991年,Vol.16, No.5,p.443-458
Attorney, Agent or Firm:
Ikeda Adult
Junichiro Sakamaki
Masakazu Noda